Transgene and NEC join forces to advance personalized cancer vaccine
TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor
TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
The last-mile healthcare delivery across 1,100 villages, with focus on maternal health, diagnostics, and chronic disease management
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
Subscribe To Our Newsletter & Stay Updated